← FDA Drug Approvals (Drugs@FDA)

ACETAMINOPHEN AND IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIONPHARMA · Approved 2023-08-01

Drug application

FDA Application #

ANDA216999

Application type

Abbreviated New Drug Application (Generic)

Brand name

ACETAMINOPHEN AND IBUPROFEN

Generic name

ACETAMINOPHEN AND IBUPROFEN

Active ingredients

ACETAMINOPHEN; IBUPROFEN

Dosage form

TABLET

Route

ORAL

Marketing status

Over-the-counter

Sponsor

BIONPHARMA

Manufacturer

AMERISOURCE BERGEN

First approval

2023-08-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown